1.Research and Clinical Application of miRNAs in Cancer Stem Cells and as Tumor Markers
Tianjin Medical Journal 2014;(10):1048-1050
The theory of cancer stem cells (CSCs) provides a new perspective for the study of cancer. CSCs doctrine presumes that tumor cells are heterogeneity, and there are cancer stem-like cells in tumors, whose proliferation is uncon-trolled. The cancer stem-like cells could form tumors from only few cells, who only account for a very small part of all the tu-mor cells. These cells with stem cells characteristics could form different extend of differentiation of tumor cells and work as source of tumor growth, recurrence and metastasis. miRNAs are widely-existed non-coding small RNAs, which regulate 1/3 of all human genes and participate in a series of essential processes of life. More and more evidences indicate that miRNAs contribute significantly to cancer generation and development. They may exhibit oncogenic activity and act as tumor suppres-sors. As one of the post-transcriptional controlling factors, they regulate biological processes of tumor related genes exten-sively and specific miRNAs expression profiles were shown in different cancers. The research of miRNA about CSCs has be-come very hot. Some studies have confirmed that miRNAs play a very important role in a variety of CSCs, which act as a new target for tumor therapy. Researchers have found that some specific miRNAs express in plasma of cancer patients, which can be used as tumor markers to assist diagnosis and prognosis. This review focused on current progress of research in function of miRNAs in CSCs and its role as tumor markers.
2.Microsurgical treatment of communicative skull base chordoma
Wei WEI ; Bing LIU ; Genglin SUN
Chinese Journal of Microsurgery 2009;32(2):98-100
Objective To investigate the appropriate surgical approaches and microsurgical resection of communicative skull base chordoma. Methods Twenty two cases of communicative skull base chordomas were microsurgically treated from 1995 to 2005 and followed up. The tumors were removed with extended anterior skull base approach in eight cases, with modified Weber-Ferguson (transmaxillary) approach in eight cases, and with transmandibular approach in six cases. Some cases were resected with combined approaches including pterional approach in 3 eases, subtemporal-zygomatie approach in 1 case, and suboccipital-retromastoid approach in 2 cases. Results Total, subtotal and partial removal of the tumors were achieved in 10 cases, 7 and 5 cases respectively. No patients died and had severe nervous system dysfunction after surgery. However, one had CSF rhinorrhea, one with infection, three with cranial never dysfunction. Twenty patients were followed-up with average 3.4 years, 12 returned to normal or partial works, 5 took care by oneself, 1 needed help, 2 died from tumor recurrence. Conclusion The treatment of communicative skull base chordoma is a challenge to neurosurgeon. The key point is the total removal of the tumor with the microsurgical technique and the appropriate approach depend on the location of the tumor. Moreover, skull base reconstruction is also important to avoid the cerebrospinal fluid leak and infection.
3.Three-dimensional finite element analysis of rigid internal fixation of mandibu lar symphysis fracture
Wei WU ; Genglin SUN ; Penglin WANG
Journal of Practical Stomatology 2001;0(03):-
Objective:To study the stress distribution dur i ng clenching and rigid internal fixation(RIF)of mandibular symphysis fracture. Methods:ANSYS software was used to establish the models of mandi bular symphysis fracture and the fracture treatment treat with RIF.The stress di stribution of mandibular symphysis fracture under different conditions were then analysed during different period of bone healthing. The value of stress shieldi ng rate was used to represent the level of stress shielding effects.Resu lts:The stress shielding rate decreased with the progression of fracture healing.The stress shielding rate produced by double plates fixation was higher than that by single plate.Stress shielding rate in the mandible fixed with tita nium plate was lower than that with steel plate.Conclusion:Minip late rigid internal fixation system may produce stress shielding effects when it is used to treat mandibular symphysis fractures. Stress shielding effects are a ffected by the attribute, the shape and the position of the plate.
4.Biomechanical analysis of mandibular bilateral sagittal split ramus osteotomy with bicortical screws internal fixation
Jian ZHOU ; Genglin SUN ; Wei WU
Journal of Practical Stomatology 2000;0(06):-
Objective: To study the mandibular bilateral sagittal split ramus osteotomy (BSSRO) with bicortical screws rigid internal fixation(RIF) with the three-dimensional finite element method, and supply directions for clinic practice.Methods:CT scanned technology and the finite element software (Ansys) were used to establish the three-dimensional finite element model of BSSRO with bicortical screws RIF. The stress distribution of the mandible and the RIF and the displacement of split mandible were calculated under three kind of occlusion situation.Results:Under the same kind of occlusion situation, the stress and displacement of the split mandible with single upper screws fixation was higher than that with the reverse "L" screws fixation, the stress and displacement of the split mandible with 2.0 mm diameter screws fixation was higher than that with 2.7 mm diameter screws fixation. With the same kind of fixation method, the stress and the displacemen of the mandible under the incisor occlusion was the highest.Conclusion:The fixation distance, position, distribution angle of the bicortical screws all have effects on the fixation stability. The patient should avoid the incisor occlusion after the surgery.
5.Biomechanical study of rigid internal fixation for maxillary LeFort Ⅰ fracture
Jian ZHOU ; Genglin SUN ; Wei WU ; Chongtao XU ; Penglin WANG
Chinese Journal of Trauma 2011;27(1):26-29
Objective To biomechanically study the fixation stability of different numbers and shapes of the titanium miniplates (L-shaped and straight four-hole miniplates) in the treatment of maxillary LeFortⅠ fracture by using three-dimensional finite element method so as to provide reference for clinical treatment of the fractures. Methods Three-dimensional finite element model of maxillary LeFortⅠ fracture was established with four kinds of rigid internal fixation (RIF) methods to calculate the stress of the maxilla and the RIF as well as the displacement of the fracture segment under three kinds of occlusion.Then, the fixation stability of different methods was compared. Results Under the same occlusion condition, the decreasing order of the displacement of the fracture segment was the L-shaped plate fixation at both buttress of the maxillary and nasal maxillary zygomatic, the straight four-hole miniplates fixation at both buttress of the maxillary and nasal maxillary zygomatic, the L-shaped plate fixation at the zygomatic maxillary buttress and the L-shaped plate fixation at naso-maxillary buttress. Under the same fixation method, the decreasing order of the displacement of the fracture segment was molar occlusion, premolar oeclusion and incisor occlusion. Conclusions The fixation stability of the L-shaped plate fixation is better than the straight four-hole miniplate fixation for the treatment of LeFortⅠ fracture. Fixation at the zygomaticmaxillary buttress is better than at the naso-maxillary buttress. Use of only two miniplates to fix the LeFort Ⅰ fracture may not be stable. Molar occlusion is not good for fracture healing.
6.Triptolide induces apoptosis of human melanoma A375 cells through the inositol-requiring enzyme 1/c-Jun N-terminal kinase signaling pathway
Donghong SUN ; Guohao LIU ; Shutong SHI ; Jun BAO ; Genglin MU ; Yue TAO
Chinese Journal of Dermatology 2023;56(10):934-939
Objective:To investigate the effect of triptolide on the apoptosis of human melanoma A375 cells through the inositol-requiring enzyme 1 (IRE1) /c-Jun N-terminal kinase (JNK) signaling pathway, and to explore its possible mechanisms.Methods:Cultured A375 cells were treated with triptolide at different concentrations of 0, 50, 100, 200 nmol/L (experimental control group, 50, 100, 200 nmol/L triptolide groups, respectively), and a blank control group (DMEM high-glucose medium without cells) was set up. Methyl thiazol tetrazolium (MTT) assay was performed to evaluate the cell viability at 24, 48, and 72 hours after the start of treatment, flow cytometry to detect cell apoptosis at 24 hours after the start of treatment, and real-time fluorescence-based quantitative PCR (RT-qPCR) and Western blot analysis were conducted to determine mRNA and protein expression of IRE1, JNK, and c-Jun, respectively. After pretreatment with the JNK inhibitor SP600125 for 72 hours, some A375 cells were then treated with 100 nmol/L triptolide for 24 hours (SP600125 + 100 nmol/L triptolide group), and the A375 cells only treated with 100 nmol/L triptolide served as control group (100 nmol/L triptolide group). Effects of triptolide on the mRNA expression of IRE1, JNK, and c-Jun in A375 cells, as well as on cell apoptosis, were investigated. Statistical analysis was performed using two-way analysis of variance, one-way analysis of variance, and Dunnett′s test.Results:After the treatment with different concentrations of triptolide for different durations, the cell viability was significantly lower in all triptolide groups than in the experimental control group ( Ftriptolide concentration = 18.36, P = 0.002), and gradually decreased over time ( F time = 8.54, P = 0.018). After 24-hour treatment, the apoptosis rate of A375 cells significantly differed among the 4 groups treated with different concentrations of triptolide ( F = 5 234.97, P < 0.001) ; additionally, the apoptosis rate was significantly higher in the 50, 100, and 200 nmol/L triptolide groups (16.99% ± 0.33%, 30.78% ± 0.40%, 38.91% ± 0.51%, respectively) than in the experimental control group (4.33% ± 0.02%, all P < 0.05), and gradually increased with the rising concentrations of triptolide. The mRNA expression levels of IRE1, JNK, and c-Jun were all significantly higher in the 50, 100, and 200 nmol/L triptolide groups than in the experimental control group (all P < 0.05), and gradually increased with the increase of triptolide concentration. Moreover, the protein expression levels of IRE1, JNK, c-Jun, p-JNK, and p-c-Jun in A375 cells in the triptolide groups also showed the same trend. After pretreatment with the JNK inhibitor SP600125 for 72 hours, the apoptosis rate was significantly lower in the SP600125 + 100 nmol/L triptolide group (21.88% ± 0.55%) than in the 100 nmol/L triptolide group without SP600125 pretreatment (30.78% ± 0.40%, t = -22.51, P < 0.001), and the mRNA expression levels of IRE1, JNK, and c-Jun were also significantly decreased in the SP600125 + 100 nmol/L triptolide group compared with the 100 nmol/L triptolide group (all P < 0.05) . Conclusion:Triptolide may induce apoptosis of human melanoma A375 cells by activating the IRE1/JNK signaling pathway.